Dose equivalence of the anti-psychotic drugs

[1]  Bankier Rg,et al.  A clinical study of mesoridazine and chlorpromazine in relapsed schizophrenic patients. , 1972 .

[2]  Palestine Ml.  Comparative study of two antipsychotic drugs in a state hospital. , 1972 .

[3]  E. Serafetinides,et al.  HALOPERIDOL, CLOPENTHIXOL, AND CHLORPROMAZINE IN CHRONIC SCHIZOPHRENIA: Chemically Unrelated Antipsychotics As Therapeutic Alternatives , 1972, The Journal of nervous and mental disease.

[4]  T. Ban.  Drug Treatment in Schizophrenia * , 1971 .

[5]  W. S. Appleton.  Psychoactive drugs: a usage guide. , 1971, Diseases of the nervous system.

[6]  B. Stotsky,et al.  HALOPERIDOL VERSUS THIORIDAZINE FOR HOSPITALIZED PSYCHOGERIATRIC PATIENTS: DOUBLE‐BLIND STUDY * , 1971, Journal of the American Geriatrics Society.

[7]  R. O. Friedel,et al.  A comparison between chlorpromazine and thiothixene in a Veterans Administration Hospital population. , 1971, Psychosomatics.

[8]  S. Gershon,et al.  Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia. , 1970, Current therapeutic research, clinical and experimental.

[9]  T. Itil,et al.  A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics. , 1970, Psychosomatics.

[10]  Fitzgerald Ch.  A double-blind comparison of haloperidol with perphenazine in acute psychiatric episodes. , 1969 .

[11]  J. Hindley,et al.  A comparison of mesoridazine and chlorpromazine in chronic psychiatric patients. , 1969, The Journal of clinical pharmacology and the journal of new drugs.

[12]  M. Clark,et al.  Evaluation of butaperazine in chronic schizophrenia , 1968, Clinical pharmacology and therapy.

[13]  Klett Cj,et al.  Predicting response to phenothiazines: the right drug for the right patient. , 1968 .

[14]  N. Kline.  Chlorpromazine in Chronic Schizophrenia , 1968, British Journal of Psychiatry.

[15]  J. Overall,et al.  Specific therapeutic actions of acetophenazine, perphenazine, and benzquinamide in newly admitted schizophrenic patients , 1967, Clinical pharmacology and therapeutics.

[16]  P. Keith-Spiegel,et al.  THE EFFECTS OF CARPHENAZINE, TRIFLUOPERAZINE AND CHLORPROMAZINE ON WARD BEHAVIOR, PHYSIOLOGICAL FUNCTIONING AND PSYCHOLOGICAL TEST SCORES IN CHRONIC SCHIZOPHRENIC PATIENTS , 1967, The Journal of nervous and mental disease.

[17]  H. Grayson,et al.  A study of thioridazine and its side-chain derivative, mesoridazine, in chronic male hospitalized psychiatric patients. , 1966, The Journal of new drugs.

[18]  L. Prasad,et al.  Haloperidol and thioridazine in treatment of chronic schizophrenics. , 1966, Diseases of the nervous system.

[19]  G. Crane,et al.  Drug responses of three hospital population samples participating in a collaborative study. , 1966, Arzneimittel-Forschung.

[20]  J. Hindley,et al.  COMPARISON OF THREE PHENOTHIAZINES ON CHRONIC PSYCHOTIC BEHAVIOR. , 1965, Diseases of the nervous system.

[21]  Peters Ll.  DRUG TREATMENT IN PSYCHIATRY. , 1964 .

[22]  J. Overall,et al.  PERPHENAZINE COMBINED WITH AMITRYPTILINE IN NEWLY ADMITTED SCHIZOPHRENICS. , 1963, American Journal of Psychiatry.

[23]  J. Overall,et al.  Comparison of acetophenazine with perphenazine in schizophrenics: Demonstration of differential effects based on computer‐derived diagnostic models , 1963 .

[24]  N. Vestre,et al.  A comparison of fluphenazine, triflupromazine, and phenobarbital in the treatment of chronic schizophrenic patients: a double-blind controlled study. , 1962, Journal of clinical and experimental psychopathology & quarterly review of psychiatry and neurology.

[25]  L. J. Epstein,et al.  A STUDY OF PHENOTHIAZINES WITH MALE AND FEMALE CHRONICALLY ILL SCHIZOPHRENIC PATIENTS , 1962, The Journal of nervous and mental disease.

[26]  K. Ota,et al.  THE COMPARATIVE EFFECTIVENESS OF SIX PHENOTHIAZINE COMPOUNDS, PHENOBARBETAL AND INERT PLACEBO IN THE TREATMENT OF ACUTELY ILL PATLENTS: GLOBAL MEASURES OF SEVERITY OF ILLNESS , 1961, The Journal of nervous and mental disease.

[27]  Schiele Bc,et al.  A comparison of thioridazine, trifluoperazine, chlorpromazine, and placebo: a double-blind controlled study on the treatment of chronic, hospitalized, schizophrenic patients. , 1961 .

[28]  F. N. Waldrop,et al.  A comparison of the therapeutic and toxic effects of thioridazine and chlorpromazine in chronic schizophrenic patients. , 1961, Comprehensive psychiatry.

[29]  L. Hollister,et al.  Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital. , 1960, The American journal of psychiatry.

[30]  S. P. Leinbach.  COUNCIL ON DRUGS , 1959 .

[31]  L. Goodman,et al.  THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .

[32]  D. Baumann.  [New drugs. 6]. , 1971, Pharmazeutische Praxis.

[33]  G. Gardos,et al.  Thiothixene and trifluoperazine in a step system. , 1970, Psychosomatics.

[34]  A. Kurland,et al.  Piperacetazine vs. Chlorpromazine in the Treatment of Schizophrenia , 1970 .

[35]  W. Hardeman,et al.  Double blind comparative study of the effects of thiothixene and thioridazine in twenty chronic schizophrenic patients. , 1970, Psychiatria, neurologia, neurochirurgia.

[36]  P. Dally.  Chemotherapy of psychiatric disorders , 1967 .

[37]  T. Hanlon,et al.  The comparative effectiveness of six phenothiazine compounds, phenobarbital and inert placebo in the treatment of acutely ill patients: personality dimensions. , 1962, The Journal of nervous and mental disease.